Vo Thomas T.

Chief Executive Officer, DirectorNutex Health, Inc. (NUTX) · full profile →Form 4 · filed May 30, 2024
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 30, 2024Buy(P)3K$0.66$2K18.1M
May 29, 2024Buy(P)4K$0.68$3K18.1M
May 28, 2024Buy(P)48K$0.70$34K18.1M
May 13, 2024Buy(P)17K$0.69$12K18.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001486189-24-000027) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about NUTX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001486189-24-000027"
Ask your agent
Use Arkolith to summarize insider buying and selling at Nutex Health, Inc.
over the last 90 days and cite the filings.